Skip to main content

Solvay invests in DMC

Through its own venture capital fund of Solvay Ventures, Solvay has made an unspecified investment in US-based DMC (Dynamic Metabolic Control) Biotechnologies. The $34-million Series B funding round also included Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures and Michelin.

Enzymaster heads for North America

Enzymatic biocatalyst specialist Enzymaster is to create a formal presence in the US, aided by business management consultancy Haig Barrett, which specialises in the life sciences and speciality chemicals. This will soon include facilities in the US, the company said.

Enzymaster is now launching business relationship models to address the specific needs of the North American market. These include fee-for-service models with client-centric IP constructs, development programmes including commercial manufacturing of engineered enzymes and collaborative engineering partnerships.

Porton opens fermentation lab

Porton Pharma Solutions, a Chinese custom API services firm, has officially put into use its fermentation pilot laboratory at Chongqing, Sichuan province.

Queen's Awards for four UK-based chemical operations

Four companies with operations in the UK have been honoured in the latest round of the Queen’s Award for Enterprise. Diamond Dispersions, Sterling Pharma Solutions and Leverton Clarke all won in the International Trade category, Biocatalysts in the Innovation category.
Subscribe to Biocatalysts